Legal & General Group PLC Castle Biosciences Inc Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Legal & General Group PLC holds 32,308 shares of CSTL stock, worth $907,854. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,308
Previous 32,308 -0.0%
Holding current value
$907,854
Previous $921,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$17.4 - $31.47 $82,302 - $148,853
4,730 Added 17.15%
32,308 $921,000
Q2 2024

Aug 14, 2024
BUY
$18.84 - $24.94 $52,883 - $70,006
2,807 Added 11.33%
27,578 $600,000
Q1 2024

May 14, 2024
SELL
$18.06 - $25.3 $902 - $1,265
-50 Reduced 0.2%
24,771 $548,000
Q4 2023

Feb 15, 2024
BUY
$12.19 - $22.43 $54,330 - $99,970
4,457 Added 21.89%
24,821 $535,000
Q3 2023

Nov 14, 2023
SELL
$13.28 - $20.3 $3,253 - $4,973
-245 Reduced 1.19%
20,364 $343,000
Q2 2023

Aug 14, 2023
BUY
$11.66 - $26.0 $117,940 - $262,990
10,115 Added 96.39%
20,609 $282,000
Q1 2023

May 15, 2023
BUY
$19.47 - $28.49 $13,122 - $19,202
674 Added 6.86%
10,494 $238,000
Q3 2022

Nov 14, 2022
BUY
$22.51 - $34.32 $15,914 - $24,264
707 Added 7.76%
9,820 $257,000
Q2 2022

Aug 22, 2022
SELL
$16.0 - $45.99 $1,504 - $4,323
-94 Reduced 1.02%
9,113 $200,000
Q1 2022

May 16, 2022
BUY
$33.17 - $46.98 $7,396 - $10,476
223 Added 2.48%
9,207 $413,000
Q4 2021

Feb 14, 2022
BUY
$39.06 - $67.58 $1,093 - $1,892
28 Added 0.31%
8,984 $385,000
Q3 2021

Nov 15, 2021
BUY
$60.13 - $77.6 $234,146 - $302,174
3,894 Added 76.93%
8,956 $596,000
Q2 2021

Aug 12, 2021
BUY
$50.07 - $76.78 $49,569 - $76,012
990 Added 24.31%
5,062 $372,000
Q1 2021

May 17, 2021
BUY
$58.92 - $97.33 $127,385 - $210,427
2,162 Added 113.19%
4,072 $279,000
Q3 2020

Nov 13, 2020
BUY
$38.47 - $52.03 $8,424 - $11,394
219 Added 12.95%
1,910 $98,000
Q2 2020

Aug 14, 2020
BUY
$27.28 - $43.01 $6,383 - $10,064
234 Added 16.06%
1,691 $64,000
Q1 2020

May 14, 2020
BUY
$23.08 - $35.53 $17,725 - $27,287
768 Added 111.47%
1,457 $43,000
Q4 2019

Feb 13, 2020
BUY
$15.74 - $35.04 $1,778 - $3,959
113 Added 19.62%
689 $24,000
Q3 2019

Nov 13, 2019
BUY
$18.09 - $27.92 $10,419 - $16,081
576 New
576 $10,000

Others Institutions Holding CSTL

# of Institutions
202
Shares Held
26M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $739M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email